Oncolytics Biotech unveils design for pancreatic cancer registration trial

Investing.comMonday, September 29, 2025 at 12:56:03 PM
Oncolytics Biotech unveils design for pancreatic cancer registration trial
Oncolytics Biotech has announced the design for a registration trial aimed at treating pancreatic cancer, a disease known for its challenging prognosis. This development is significant as it could lead to new treatment options for patients suffering from this aggressive cancer, potentially improving survival rates and quality of life. The trial's design reflects a commitment to advancing cancer research and addressing unmet medical needs.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Enhertu shows significant improvement in high-risk breast cancer
PositiveFinancial Markets
Recent clinical trials have shown that Enhertu, a targeted therapy, significantly improves outcomes for patients with high-risk breast cancer. This is a game-changer in treatment options, as it offers hope to those facing aggressive forms of the disease. The results highlight the importance of personalized medicine and could lead to more effective strategies in managing breast cancer, ultimately saving lives.
Latest from Financial Markets
Trump renews threat to impose 100% tariffs on non-US made movies
NegativeFinancial Markets
President Trump has reignited his threat to impose 100% tariffs on movies not made in the United States, claiming that the American film-making industry has been 'stolen' by foreign countries. This move could have significant implications for the film industry, potentially raising costs for consumers and affecting international collaborations.
Ormat Technologies stock hits 52-week high at 95.39 USD
PositiveFinancial Markets
Ormat Technologies has reached a significant milestone as its stock price hit a 52-week high of 95.39 USD. This achievement reflects the company's strong performance and investor confidence in its renewable energy solutions. As the demand for sustainable energy sources continues to grow, Ormat's success is a positive indicator for the industry and could attract more investors looking for opportunities in green technology.
Trump administration tightens export controls on Chinese companies
NegativeFinancial Markets
The Trump administration has implemented stricter export controls targeting Chinese companies, particularly affecting subsidiaries of entities that have been blacklisted by the US government. This move is significant as it reflects ongoing tensions between the US and China, impacting trade relations and potentially hindering the operations of affected companies. The tightening of these controls could lead to further economic repercussions and escalate the trade conflict.
Honeywell's West Lays Out Future Energy Needs
PositiveFinancial Markets
In a recent interview, Honeywell's Energy and Sustainability Solutions President & CEO Ken West emphasized the growing demand for energy, predicting that the world will require more power in the future. This insight is crucial as it highlights the need for innovative solutions and sustainable practices to meet increasing energy needs, making it a significant topic for businesses and policymakers alike.
Carnival Q3 2025 presentation slides: Record $2B profit and third guidance raise
PositiveFinancial Markets
Carnival Corporation has reported a record profit of $2 billion for the third quarter of 2025, marking a significant milestone for the cruise line industry. This impressive financial performance not only highlights the company's recovery post-pandemic but also reflects strong consumer demand for travel experiences. Additionally, Carnival raised its guidance for the upcoming quarters, indicating confidence in sustained growth. This news is crucial as it signals a robust rebound in tourism and could positively impact related sectors.
CorVel Corp stock hits 52-week low at $77.64
NegativeFinancial Markets
CorVel Corp's stock has reached a 52-week low, dropping to $77.64, which raises concerns among investors about the company's financial health and market performance. This decline could impact investor confidence and may lead to further scrutiny of CorVel's business strategies and future prospects.